Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Alphapharm Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (849)
Cancellation by sponsor (780)
Prescription medicine registration (54)
Cancellation or suspension (44)
Australian Public Assessment Report (AusPAR) (3)
Designation or determination (3)
Prescription medicine decision summary (2)
Section 14, TGO91 consent (1)

Date

2024 (18)
2023 (84)
2022 (230)
2021 (265)
2020 (113)
2019 (35)
2018 (66)
2017 (364)
2016 (34)
2015 (22)
2014 (48)
2013 (40)
2012 (61)
2011 (28)
2010 (46)
2009 (25)
2008 (10)
2007 (28)
2006 (6)
2005 (17)
2004 (15)
2003 (33)
2002 (15)
2001 (4)
2000 (14)
1999 (9)
1998 (8)
1997 (11)
1996 (10)
1995 (7)
1994 (6)
1993 (12)
1992 (11)
1991 (41)

Results for "[search-keyword]"

Search

Sponsor content

1736 result(s) found, displaying 1211 to 1220

GALANTYL galantamine (as hydrobromide) 16 mg modified release capsule bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
GALANTYL galantamine (as hydrobromide) 8 mg modified release capsule bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
GALANTYL galantamine (as hydrobromide) 24 mg modified release capsule bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
ZOPRAL lansoprazole 15 mg enteric capsule bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
ZOPRAL lansoprazole 30 mg enteric capsule bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
CEPTOLATE mycophenolate mofetil 500 mg tablet bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
ADESAN HCT 16/12.5 candesartan cilexetil/hydrochlorothiazide 16 mg/12.5 mg tablet bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
ACRIS risedronate sodium 35 mg film-coated tablet bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
CANDESARTAN HCT ALPHAPHARM 32/12.5 candesartan cilexetil/hydrochlorothiazide 32 mg/12.5 mg tablets bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
LENOFIL fenofibrate 145 mg film-coated tablets bottle Cancelled under s30(1)(c) of the Act

30 May 2017

Cancellation by sponsor

Requested by Alphapharm Pty Ltd

Pages

First page
Previous page
…
Page 118
Page 119
Page 120
Page 121
Current page 122
Page 123
Page 124
Page 125
Page 126
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.